Literature DB >> 15793434

Auricular arteriovenous malformation: evaluation, management, and outcome.

June K Wu1, Annouk Bisdorff, Françoise Gelbert, Odile Enjolras, Patricia E Burrows, John B Mulliken.   

Abstract

BACKGROUND: The external ear is the second most common site for extracranial arteriovenous malformation in the head and neck.
METHODS: This retrospective review of 41 patients with auricular arteriovenous malformation was based on medical records, imaging studies, and photographs. Data were collected on natural history, progression, and outcome; patients were questioned about quality of life after treatment.
RESULTS: The median age at initial presentation was 26 years (range, 1 to 55 years), and Schobinger stage was I in two patients, II in 19 patients, and III in 20 patients. No patients had a Schobinger stage of IV. Expansion occurred during childhood in seven patients, adolescence in 14 patients, pregnancy in 10 patients, and adulthood in 10 patients. Distribution of auricular and extra-auricular arteriovenous malformation was not limited to "watershed" areas between vascular territories (angiosomes). Twelve patients were untreated (follow-up, 0.5 to 6 years). Mean follow-up time for the 29 treated patients was 5.19 years (range, 1 to 18.75 years). Proximal ligation in nine patients caused progression: eight of them underwent amputation and one had embolization. Fifteen patients had embolization only: the arteriovenous malformation worsened and amputation was necessary in six patients; in the remaining nine patients, two improved, four persisted, and three worsened. Of 20 patients who had auricular amputation, 16 (80 percent) were controlled, three (15 percent) improved, and one had unresectable, residual cervicofacial arteriovenous malformation. Of 22 of 29 treated patients surveyed, 81 percent were satisfied with their management. Hearing was either unaffected (n = 15) or diminished (n = 5); two patients noted decreased sound localization.
CONCLUSIONS: The authors recommend periodic evaluation for stage I to II auricular arteriovenous malformation and intervention if there is evolution to stage III. Preoperative embolization and partial or total amputation effectively control auricular and para-auricular arteriovenous malformation. Embolization can be palliative in children or in patients who are not psychologically prepared for amputation. Extensive extra-auricular arteriovenous malformation requires individualized endovascular therapy and resection.

Entities:  

Mesh:

Year:  2005        PMID: 15793434     DOI: 10.1097/01.prs.0000154207.87313.de

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  15 in total

1.  Spontaneous arteriovenous malformation of the ear.

Authors:  Kishore Chandra Prasad; Sampath C Prasad; Sujith Shahul
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-30

2.  [Near-total ear amputation: anatomical bases and management].

Authors:  N H Nicolay; A D Bruno; K E Follmar; T H Stokes; D L Gonyon; J R Marcus; D Erdmann
Journal:  Chirurg       Date:  2007-09       Impact factor: 0.955

Review 3.  Intraosseous venous malformation of the zygomatico-orbital complex. Case report and literature review with focus on confusions in vascular lesion terms.

Authors:  Zoltán Fábián; György Szabó; Cecilia Petrovan; Karin Ursula Horváth; Botond Babicsák; Kálmán Hüttl; Zsolt Németh; Sándor Bogdán
Journal:  Oral Maxillofac Surg       Date:  2018-04-13

4.  Long-term results of ethanol sclerotherapy with or without adjunctive surgery for head and neck arteriovenous malformations.

Authors:  Byungjun Kim; Keonha Kim; Pyoung Jeon; Sungtae Kim; Hyungjin Kim; Hongsik Byun; Dongik Kim; Youngwook Kim
Journal:  Neuroradiology       Date:  2015-01-07       Impact factor: 2.804

5.  Head and neck arteriovenous malformations: results of ethanol sclerotherapy.

Authors:  J Pekkola; K Lappalainen; P Vuola; T Klockars; P Salminen; A Pitkäranta
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-05       Impact factor: 3.825

6.  Endovascular treatment of head and neck arteriovenous malformations.

Authors:  A A Dmytriw; K G Ter Brugge; T Krings; R Agid
Journal:  Neuroradiology       Date:  2014-01-28       Impact factor: 2.804

7.  Leg ulcer due to multiple arteriovenous malformations in the lower extremity of an elderly patient.

Authors:  Takashi Ueda; Kenichi Tanabe; Miho Morita; Chihoko Nakahara; Kensei Katsuoka
Journal:  Int Wound J       Date:  2014-04-10       Impact factor: 3.315

8.  Absence of skin discoloration after transarterial embolization of a subcutaneous auricular arteriovenous malformation with PHIL.

Authors:  Matthijs In 't Veld; Peter Wa Willems
Journal:  Interv Neuroradiol       Date:  2016-06-12       Impact factor: 1.610

9.  Japanese clinical practice guidelines for vascular anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  Jpn J Radiol       Date:  2020-04       Impact factor: 2.374

10.  Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  J Dermatol       Date:  2020-03-22       Impact factor: 4.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.